Khayal Tamer I's Form 4/A amendment
AmendedTransMedics Group, Inc. (TMDX) · filed May 14, 2024
- Accession no.
- 0000950170-24-059830
- Filed
- May 14, 2024
- Rule 10b5-1 plan
- Checked
- Original filed
- May 8, 2024
This filing lists no transactions. It carries over 3 transactions from the original filing that it did not restate. Open-market sales total $759.5K.
This amendment restates part of 0000950170-24-055795 (filed May 8, 2024). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Khayal Tamer ICIK 0001430462 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0000950170-24-055795 (filed May 8, 2024).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 6, 2024 | Common Stock | MOption exerciseAcquired | +5,839 | $66.10 | +$385,957.9 | 15,631 | Direct | |
| May 6, 2024 | Common Stock | SSaleDisposed | −5,839 | $130.07F2 | −$759,478.73 | 9,792 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 6, 2024 | Common Stock | MOption exerciseDisposed | −5,839 | $0.00 | $0 | 14,183 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F2
The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $130.00 to $130.23, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
This amendment has no footnotes.
Remarks
This amended Form 4 corrects a clerical error in the Form 4 filed by the Reporting Person on May 8, 2024, which incorrectly reported that 11,051 shares of the Issuer's Common Stock beneficially owned by the Reporting Person were owned by the Tamer Ibrahim Ahmed Khayal Trust. This amended Form 4 corrects the Form 4 to report that 11,051 of the shares of the Issuer's Common Stock reported as being owned by the Tamer Ibrahim Ahmed Khayal Trust were owned directly by the Reporting Person.